(Q42539590)

2 November 2017

title

An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes (English)

1 reference

2 November 2017

N Masubuchi

1

1 reference

2 November 2017

A P Li

series ordinal

2

1 reference

2 November 2017

O Okazaki

series ordinal

3

1 reference

2 November 2017

language of work or name

1 reference

1 July 1998

1 reference

Chemico-biological Interactions

2 November 2017

published in

1 reference

2 November 2017

volume

114

1 reference

2 November 2017

issue

1-2

1 reference

2 November 2017

page(s)

1-13

1 reference

Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Comparative metabolism of SC-42867 and SC-51089, two PGE2 antagonists, in rat and human hepatocyte cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Evaluation of drug interactions in intact hepatocytes: Inhibitors of terfenadine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Substrates of human hepatic cytochrome P450 3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Effects of lansoprazole on pharmacokinetics and metabolism of theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Lansoprazole does not affect the bioavailability of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2898%2900031-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-2797(98)00031-3

1 reference

2 November 2017

1 reference